Read More
Low PE Pharma Giant Jumps Over 4% After Q4FY26 Results; PAT Declines 55%, A...
Cipla reported Q4FY26 revenue of Rs 6,541 crore with EBITDA margin at 15.2 per cent, while the compa...
Articles tagged with "Cipla Ltd"
Read More
Cipla Q3FY26 Results: Return to Double-Digit Growth in India...
Founded in 1935, Cipla is a global pharmaceutical leader driven by its core purpose of "Caring for L...
Read More
Cipla Announces Temporary Supply Pause for Lanreotide Following USFDA Audit...
This has been notified of a temporary suspension in the production of Lanreotide Injection....
Read More
Pharma Company Has Received Final Approval From United States Food and Drug...
The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-...
Read More
Overnight Digest: Stocks to keep an eye on January 19!...
Watch out for these large-cap stocks in Thursday’s trading session!...